kombiglyze xr tablet 5mg1000mg
astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin - tablet, film coated, extended release - 1000mg - metformin hydrochloride + 0.5% magnesium stearate 1000mg; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin 5.0mg
kombiglyze xr tablet 5mg500mg
astrazeneca singapore pte ltd - metformin hydrochloride + 0.5% magnesium stearate; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin - tablet, film coated, extended release - 500mg - metformin hydrochloride + 0.5% magnesium stearate 500mg; saxagliptin hydrochloride anhydrous 5.58mg eqv saxagliptin 5.0mg
onglyza tablets 2.5 mg
astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin - tablet, film coated - 2.5 mg - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin 2.5 mg
onglyza tablets 5 mg
astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 5.58 mg eqv saxagliptin - tablet, film coated - 5 mg - saxagliptin hydrochloride (anhydrous) 5.58 mg eqv saxagliptin 5 mg
symbicort turbuhaler 1604.5 mcgdose
astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 160 mcg/dose - budesonide 160 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose
symbicort turbuhaler 804.5 mcgdose
astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 80 mcg/dose - budesonide 80 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose
astrazeneca water for injections 2ml ampoule
astrazeneca pty ltd - water for injections -
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastic agents - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above
fluenz tetra
astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influenza, human - influenza vaccines, influenza, live attenuated - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. the use of fluenz tetra should be based on official recommendations.
evusheld 100 mgml solution for injection
astrazeneca sdn. bhd. - tixagevimab; cilgavimab -